Steve O’Loughlin

Chief Financial Officer and Corporate Secretary (Principal Financial and Accounting Officer)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ATNM

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer	$436,800	$145,000	—	—	—	—	$581,800
2023	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer	$420,000	$170,000	—	$900,000	—	—	$1,490,000
2022	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer	$400,000	$185,000	—	$891,144	—	—	$1,476,144
2021	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer	$370,000	$150,000	—	$447,034	—	—	$967,034
2020	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer	$330,000	$90,000	—	$398,640	—	—	$818,640
2019	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer, former Principal Financial Officer	$293,550	$85,000	—	$64,364	—	—	$442,914
2018	Actinium Pharmaceuticals, Inc. (ATNM)	Chief Financial Officer, former Principal Financial Officer	$285,000	$75,000	—	$145,552	—	—	$505,552

Earnings-call appearances and filed executive appointments or departures, newest first.